Facial Aesthetics
Pemphigus Vulgaris (PV)
- Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect
- Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris
- Pemphigus Vulgaris
- FDA approves Rituxan for pemphigus vulgaris
Prurigo Nodularis
- Prurigo Nodularis Signs and Symptoms – AAD Patient Resource
- 2022 Prurigo Nodularis Facts, Symptoms, Testing and Treatment – JAMA Patient Resource
- 2022 JAAD Health-related Quality of Life and Economic Burden of Prurigo Nodularis
- Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials (PRIME and PRIME2)
- Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
- Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase
- Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
- Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances
- Barriers to Successful Management of Prurigo Nodularis: Demographic Characteristics, Ethnic Differences, and Chronic Comorbidities
- Psychiatric Comorbidity and the Impact of Socioeconomic Status in Prurigo Nodularis
- Immunotargets and Immunotherapy for Prurigo Nodularis
- 2021 United States Expert Panel Consensus on the Diagnosis and Management of Prurigo Nodularis
- Pathophysiology, Diagnosis and Pharmacologic Treatment of Prurigo Nodularis
- Etiology, Clinical Diagnosis, Treatment Planning and Patient Education for Prurigo Nodularis
- Phototherapy for the Management of Chronic Itch in Prurigo Nodularis
Psoriasis
- Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review
- Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis
- Psoriatic Disease Information for Parents/Caregivers
- Treatments for Psoriatic Disease – For Patients
- Understanding Psoriatic Disease – For Patients
- Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis
- Psoriasis Clinical Guideline from the American Academy of Dermatology
- National Psoriasis Foundation
- Psoriasis Q & A – For Patients
